Mangoceuticals subsidiary creates Series A Preferred Stock granting CEO 51% voting control

MANGOCEUTICALS, INC.

Series A Preferred Stock of M&P subsidiary gives holders 51% of total vote on all shareholder matters.
100 shares designated; expected to be issued to CEO Jacob Cohen under his employment agreement.
M&P cannot amend charter or issue more shares without 66-2/3% approval of Series A holders.
Designation filed Jan 9, 2025, effective same date; filed with Texas SOS on Jan 15.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.